Indications for use GLP-1 receptor agonists are used to manage type 2 diabetes and, in some cases, for weight loss in people with obesity or who are overweight with related health conditions
A proof-of-concept trial in Nature Medicine found that supplementation with a pasteurized form of Akkermansia in overweight and obese volunteers was safe, well tolerated, and associated with improvements in several metabolic markers, including insulin sensitivity and blood lipids (Depommier et al., 2019)
PCOS is also linked to other health conditions, including metabolic issues such as insulin resistance and type 2 diabetes ( 3 )
Patients with a history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2) are at a higher risk of developing thyroid C-cell tumors
V.Gonzlez-MolesM
In contrast, for HOMA-IR, LC n3-PUFA supplementation was associated with a modest but statistically significant reduction (SMD: 0.42